SCC Interim Hazardous Drugs (NIOSH TABLE 1) PPE Guidelines during the COVID-19 Pandemic
The COVID-19 pandemic is creating a growing shortage of personal protective equipment (PPE). SCC has been asked to look at safe handling practices surrounding hazardous drug administration and how we can help to conserve PPE
A Note from Dr Brett Glotzbecker - Chief Medical Officer, Seidman
Additional testing criteria for patients who have a history of a hematologic malignancy, undergone stem cell transplant or CAR-T cell therapy or patients with Sickle Cell disease.
New! Coronavirus (COVID-19) Questions and Answers
Read what's new - download the document!